Therapy News and Research

RSS

Older adults under severe financial strain more likely to die within six months after heart attack

Older adults who report being under severe financial strain were substantially more likely to die within six months of having a heart attack compared to those with moderate or no financial strain, according to a new study led by University of Maryland School of Medicine researchers.

7 Mar 2022

Biodegradable nanoparticle used in medical sutures could help combat scleroderma

Investigators have discovered that a biodegradable nanoparticle used in medical sutures could combat a rare, sometimes-fatal autoimmune disease.

7 Mar 2022

Some blood cells remain in tissues for years, research finds

Human immune cells not only circulate in the blood, but can also occupy certain tissues and sometimes remain there for years.

7 Mar 2022

Slowing down the DNA replication speed increases cell reprogramming efficiency

Adult cells in our body can only give rise to the same cell type. For example, a skin cell cannot give rise to a muscle cell but to skin cells only.

7 Mar 2022

New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies.

7 Mar 2022

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Researchers evaluated the effectiveness of regdanvimab on clinical outcomes in patients with mild to moderate COVID-19.

7 Mar 2022

Study offers new hope for patients coping with spinal cord injuries

By employing artificial intelligence (AI) and robotics to formulate therapeutic proteins, a team led by Rutgers researchers has successfully stabilized an enzyme able to degrade scar tissue resulting from spinal cord injuries and promote tissue regeneration.

7 Mar 2022

World Trade Center responders have increased levels of mutations that escalate blood cancer risk

Scientists from Vanderbilt-Ingram Cancer Center (VICC) collaborated with researchers from New York to determine that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease, according to a study published March 7 in Nature Medicine.

7 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

7 Mar 2022

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

Researchers discovered compounds able to inhibit SARS-CoV-2 macrodomain 1 and adenosine diphosphate-ribose binding via high throughput screening.

7 Mar 2022

Study explores COVID-19 vaccine effectiveness in ankylosing spondylitis patients

Researchers estimated the immunogenicity of SARS-CoV-2 vaccination in a Belgian cohort of patients with ankylosing spondylitis.

7 Mar 2022

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

A new study discusses the outcomes of idiopathic pulmonary fibrosis patients with confirmed SARS-CoV-2 infection.

6 Mar 2022

Combating COVID cytokine storm with targeted nucleic acid therapies

Researchers examine current nucleic acid-based treatments against COVID-19 and their methods of action.

6 Mar 2022

First-of-its-kind, innovative application for wheelchair users living with tetraplegia

Brooks Rehabilitation recently announced that the MagTrack study, a collaborative research endeavor with the Georgia Tech School of Electrical and Computer Engineering, has been successfully completed.

4 Mar 2022

Pilot study opens the door to a promising new therapeutic alternative for PTSD patients

PTSD, or post-traumatic stress disorder, doesn't discriminate. It affects about 15 million adults in the U.S. each year.

4 Mar 2022

T-cell cytokine and fatty acid work together to trigger a type of cell death

Researchers at the University of Michigan Rogel Cancer Center found that a cytokine, a category of protein that acts as messengers in the body, and a fatty acid can work together to trigger a type of cell death previously defined by studies with synthetic molecules.

4 Mar 2022

Combination treatment could benefit smokers who also drink heavily

One in five people who smoke also drink heavily, but they show worse outcomes than non-heavy drinkers in quitting smoking and are often excluded from smoking cessation trials.

4 Mar 2022

High-fat diet combined with liquid fructose intake accelerates fat accumulation in the liver

A high-fat diet is not enough to cause short-term fatty liver disease. However, if this diet is combined with the intake of beverages sweetened with liquid fructose, the accumulation of fats in the liver accelerates and hypertriglyceridemia —a cardiovascular risk factor— can appear.

4 Mar 2022

COVID-19 and the life sciences; what have we learned and where are we going?

News-Medical attended the 2022 SLAS press briefing where Peter Simpson, Michael Girardi, and Simon Meffan-Main gave their thoughts on the life sciences sector post-COVID-19.

From Society for Laboratory Automation and Screening (SLAS) 4 Mar 2022

Study finds how genetic baggage can accumulate in the genomes of normal and mutant animals

You are probably familiar with the term that some people carry "a lot of extra baggage." Usually that term refers to that person's emotional history, but in genetics and our genomes, "extra baggage" can also describe the transposons lurking in our genomes, a historical record of our genomes surviving traumatic invasions during evolution.

4 Mar 2022

Therapy News and Research

Older adults under severe financial strain more likely to die within six months after heart attack

Biodegradable nanoparticle used in medical sutures could help combat scleroderma

Some blood cells remain in tissues for years, research finds

Slowing down the DNA replication speed increases cell reprogramming efficiency

New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Study offers new hope for patients coping with spinal cord injuries

World Trade Center responders have increased levels of mutations that escalate blood cancer risk

Current progress in SARS-CoV-2 vaccine candidates

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

Study explores COVID-19 vaccine effectiveness in ankylosing spondylitis patients

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

Combating COVID cytokine storm with targeted nucleic acid therapies

First-of-its-kind, innovative application for wheelchair users living with tetraplegia

Pilot study opens the door to a promising new therapeutic alternative for PTSD patients

T-cell cytokine and fatty acid work together to trigger a type of cell death

Combination treatment could benefit smokers who also drink heavily

High-fat diet combined with liquid fructose intake accelerates fat accumulation in the liver

COVID-19 and the life sciences; what have we learned and where are we going?

Study finds how genetic baggage can accumulate in the genomes of normal and mutant animals

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News